![Erik Bissessar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erik Bissessar
Fondateur chez Eribis Pharmaceuticals AB
Postes actifs de Erik Bissessar
Sociétés | Poste | Début | Fin |
---|---|---|---|
Eribis Pharmaceuticals AB
![]() Eribis Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Eribis Pharmaceuticals AB, ('Eribis') was founded by Erik Bissessar and co-founded by Herman Krapf. Karolinska Development is the primary investing partner. The basis of Eribis is the Company's unique competence in developing peptides for the pharmacological use for treatment of several clinical indications. The company's main focus is on developing new, effective and safe drugs for the treatment of cardiovascular disorders, in particular acute myocardial ischemia, and also for surgical preconditioning. The Company is based on research in the fields of peptide chemistry and pharmacology. The main goal for Eribis is to develop its Candidate Drug to meet the market's demand for new and improved treatment in the field of cardio-protection. Other medical indications may be considered at a later stage. | Directeur/Membre du Conseil | 01/01/2006 | - |
Fondateur | 28/10/2009 | - | |
Corporate Officer/Principal | 01/01/2006 | - |
Historique de carrière de Erik Bissessar
Anciens postes connus de Erik Bissessar
Sociétés | Poste | Début | Fin |
---|---|---|---|
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
Smithkline Beecham Plc
![]() Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | - | - |
The Iams Co., Inc.
![]() The Iams Co., Inc. Food: Specialty/CandyConsumer Non-Durables The Iams Co. manufactures and distributes pet food The company was founded by Paul Iams in 1946 and is headquartered in Dayton, OH. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Suède | 3 |
Etats-Unis | 2 |
Royaume-Uni | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Director/Board Member | 1 |
Founder | 1 |
Sectorielle
Health Technology | 3 |
Consumer Non-Durables | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Eribis Pharmaceuticals AB
![]() Eribis Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Eribis Pharmaceuticals AB, ('Eribis') was founded by Erik Bissessar and co-founded by Herman Krapf. Karolinska Development is the primary investing partner. The basis of Eribis is the Company's unique competence in developing peptides for the pharmacological use for treatment of several clinical indications. The company's main focus is on developing new, effective and safe drugs for the treatment of cardiovascular disorders, in particular acute myocardial ischemia, and also for surgical preconditioning. The Company is based on research in the fields of peptide chemistry and pharmacology. The main goal for Eribis is to develop its Candidate Drug to meet the market's demand for new and improved treatment in the field of cardio-protection. Other medical indications may be considered at a later stage. | Health Technology |
The Iams Co., Inc.
![]() The Iams Co., Inc. Food: Specialty/CandyConsumer Non-Durables The Iams Co. manufactures and distributes pet food The company was founded by Paul Iams in 1946 and is headquartered in Dayton, OH. | Consumer Non-Durables |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Smithkline Beecham Plc
![]() Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
- Bourse
- Insiders
- Erik Bissessar
- Expérience